2016, 2017 + 2018
Runner-up in 2019
Trends in cybersecurity, data privacy and compliance
Manage HR globally with our employment and equity compensation compliance team.
Orrick has advised San Francisco-based synthetic biology company Twist Bioscience (NASDAQ: TWST) on its $107.4 million follow-on offering.
Pitchbook, 2018 & 2019
Pitchbook, 2019 and 4 years in a row
Chambers and Partners, 2019
Legal 500, 2019
Law360, 2018 and 3 times